223 related articles for article (PubMed ID: 31497205)
1. Expression profile and prognostic values of STAT family members in non-small cell lung cancer.
Yang M; Chen H; Zhou L; Chen K; Su F
Am J Transl Res; 2019; 11(8):4866-4880. PubMed ID: 31497205
[TBL] [Abstract][Full Text] [Related]
2. The prognostic values of signal transducers activators of transcription family in ovarian cancer.
Li S; Sheng B; Zhao M; Shen Q; Zhu H; Zhu X
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28536310
[TBL] [Abstract][Full Text] [Related]
3. Prognostic roles of signal transducers and activators of transcription family in human breast cancer.
Wang S; Yu L; Shi W; Li X; Yu L
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29326301
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the mRNA expression of members of the HSP90 family in non-small cell lung cancer.
Liu K; Kang M; Li J; Qin W; Wang R
Exp Ther Med; 2019 Apr; 17(4):2657-2665. PubMed ID: 30930968
[TBL] [Abstract][Full Text] [Related]
5. Mining the prognostic significance and immune infiltration of
Zhou Y; Jiang S; Yu S; Zhu L; Liu Y; Li S; Hao N; Ren Y
Gland Surg; 2022 Apr; 11(4):720-741. PubMed ID: 35531108
[TBL] [Abstract][Full Text] [Related]
6. Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter.
Hou GX; Liu P; Yang J; Wen S
PLoS One; 2017; 12(3):e0174515. PubMed ID: 28355294
[TBL] [Abstract][Full Text] [Related]
7. Distinct prognostic values and potential drug targets of ALDH1 isoenzymes in non-small-cell lung cancer.
You Q; Guo H; Xu D
Drug Des Devel Ther; 2015; 9():5087-97. PubMed ID: 26366059
[TBL] [Abstract][Full Text] [Related]
8. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
Wu HT; Liu J; Li GW; Shen JX; Huang YT
Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733
[TBL] [Abstract][Full Text] [Related]
9. Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer.
Xiong J; Zhang X; Chen X; Wei Y; Lu DG; Han YW; Xu J; Yu D
Oncotarget; 2017 Feb; 8(8):13157-13165. PubMed ID: 28061457
[TBL] [Abstract][Full Text] [Related]
10. Immunoexpression analysis of selected JAK/STAT pathway molecules in patients with non- small-cell lung cancer.
Pastuszak-Lewandoska D; Domańska-Senderowska D; Kordiak J; Antczak A; Czarnecka KH; Migdalska-Sęk M; Nawrot E; Kiszałkiewicz JM; Brzeziańska-Lasota E
Pol Arch Intern Med; 2017 Nov; 127(11):758-764. PubMed ID: 28972958
[TBL] [Abstract][Full Text] [Related]
11. Expression of Microtubule-Associated Proteins in Relation to Prognosis and Efficacy of Immunotherapy in Non-Small Cell Lung Cancer.
Luo J; Hu Q; Gou M; Liu X; Qin Y; Zhu J; Cai C; Tian T; Tu Z; Du Y; Deng H
Front Oncol; 2021; 11():680402. PubMed ID: 34660263
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of prognosis and therapeutic response for STAT family in pancreatic cancer.
He Z; Zhang X; Wang S; Dai X; Wang Q; Lu Q; Lu H; Wu Y; Wang H; Wang X; Wang H; Liu Y
Heliyon; 2023 May; 9(5):e16150. PubMed ID: 37215832
[TBL] [Abstract][Full Text] [Related]
13. Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.
Zeng Y; Li N; Liu W; Zeng M; Cheng J; Huang J
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2447-2460. PubMed ID: 32627077
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the prognostic and diagnostic values of ALKBH family members in non-small cell lung cancer.
Wang L; Feng X; Jiao Z; Gan J; Meng Q
Pathol Res Pract; 2022 Mar; 231():153809. PubMed ID: 35180653
[TBL] [Abstract][Full Text] [Related]
15. Signal transducer and activator of transcription family is a prognostic marker associated with immune infiltration in endometrial cancer.
Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H
J Clin Lab Anal; 2022 Apr; 36(4):e24315. PubMed ID: 35244291
[TBL] [Abstract][Full Text] [Related]
16. Distinct prognostic roles of HSPB1 expression in non-small cell lung cancer.
Huang ZC; Li H; Sun ZQ; Zheng J; Zhao RK; Chen J; Sun SG; Wu CJ
Neoplasma; 2018; 65(1):161-166. PubMed ID: 29017331
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of 4.1 mRNA expression in non-small cell lung cancer.
Xiang Y; Shan F; Feng G; Guo K; Ruan S; Huang D
Transl Cancer Res; 2021 Mar; 10(3):1216-1228. PubMed ID: 35116449
[TBL] [Abstract][Full Text] [Related]
18. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
19. Prognostic roles of mitochondrial transcription termination factors in non-small cell lung cancer.
Sun S; Wu C; Yang C; Chen J; Wang X; Nan Y; Huang Z; Ma L
Oncol Lett; 2019 Oct; 18(4):3453-3462. PubMed ID: 31516563
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics Analysis of Expression Profiles and Prognostic Values of the Signal Transducer and Activator of Transcription Family Genes in Glioma.
Ji W; Liu Y; Xu B; Mei J; Cheng C; Xiao Y; Yang K; Huang W; Jiao J; Liu H; Shao J
Front Genet; 2021; 12():625234. PubMed ID: 34276757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
